Partnership equips Brain Balance to scale its national network with a unified EHR that integrates clinical, financial, and operational workflows,...
Grow Therapy acquires Neosync to set a new standard in mental health privacy. NEW YORK, Sept. 25, 2025 /PRNewswire/ --...
Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment...
HOUSTON, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader...
European-inspired social club for parents-to-be blends expert-led education with lasting friendships. Registration now open for November 2025 cohorts. The journey...
Vancouver, Canada, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Mentavi's clinically validated, asynchronous ADHD assessment - recently published in the Journal of Clinical Psychiatry - shortens wait times from...
As rates of anxiety, burnout, and overwhelm reach record levels, the Encinitas-based center underscores self-care as a practical, community-driven approach...
The Encinitas facility shines a light on families, first responders, and individuals in recovery while calling for education, compassion, and...
Small-group EDI integration breaks market norms bringing automation and accuracy to ancillary benefits administration for groups of any size. INDIANAPOLIS, Sept....
CHICAGO, Sept. 24, 2025 /PRNewswire/ -- Stratos Health, a leading innovator in fully insured group supplemental executive and employee benefits,...
Innovator of HD-EEG releases world’s most advanced EEG brain monitoring technology for neuroscience research EGI GES 500 Next-Generation HD-EEG Platform...
New Alignment Health study shows nearly 2 in 5 seniors who experience loneliness say it’s impacting their health, 1 in...
Toronto, Ontario--(Newsfile Corp. - September 23, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an...
SAN FRANCISCO, CA / ACCESS Newswire / September 23, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte,...
ALBANY, NEW YORK / ACCESS Newswire / September 23, 2025 / Rivia Mind, a mental health practice providing compassionate, evidence-based...
Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients...
SAN FRANCISCO, CA / ACCESS Newswire / September 22, 2025 / MentalHealth.com today announced its acquisition of Therapy.ai, a move...
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®...
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with...